Fulgent Genetics, Inc. (FLGT)
Nasdaq: FLGT · Services-Medical Laboratories · El Monte, CA · filing with the SEC since 2016
Who runs Fulgent Genetics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Hsieh Ming
Chief Executive Officer. First filing May 2016, latest Sep 3, 2026, 14 filings in all.
Officers reporting now
4
of 7 people with a filing in the last fifteen months
Directors reporting now
3
12 people on the record since 2016
Officerssales are open-market, Oct 28, 2025 to Oct 28, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Xie Jian | President and COO | Aug 2020 | Oct 28, 2026 | 8 · $500,000 |
| Kim Paul | CFO and Treasurer | Aug 2016 | Oct 28, 2026 | none |
| Gao Hanlin | Chief Scientific Officer | May 2016 | Oct 28, 2026 | 7 · $200,000 |
| Hsieh Ming | Chief Executive Officer | May 2016 | Sep 3, 2026 | none |
Directorssales are open-market, Oct 28, 2025 to Oct 28, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Groves Regina E | director | Jan 2023 | May 18, 2026 | none |
| Marsh Linda | director | Aug 2019 | May 18, 2026 | none |
| Nohaile Michael | director | Aug 2022 | May 18, 2026 | none |
Owners of more than 10% of a classsales are open-market, Oct 28, 2025 to Oct 28, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ming Hsieh Trust | 10% owner | Dec 2020 | Mar 31, 2026 | none |
Earlier names on the record6, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.